Cytokinetics, Inc. (CYTK)
62.58
-0.86
(-1.35%)
USD |
NASDAQ |
Jan 16, 16:00
62.54
-0.04
(-0.06%)
After-Hours: 20:00
Cytokinetics Shareholders Equity (Quarterly): -521.12M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 18.55B |
| Molina Healthcare, Inc. | 4.191B |
| Jasper Therapeutics, Inc. | 11.57M |
| Fortrea Holdings, Inc. | 580.80M |
| Lifecore Biomedical, Inc. | 36.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.437B |
| Total Liabilities (Quarterly) | 1.958B |
| Debt to Equity Ratio | -2.297 |
| Current Ratio | 6.876 |
| Net Debt Paydown Yield | -1.21% |